Abstract
The nuclear envelope (NE) surrounds the nucleus and separates it from the cytoplasm. The NE is not a passive structural component, but rather contributes to various cellular processes such as genome organization, transcription, signaling, and stress responses. Although the NE is mostly a smooth surface, it also forms invaginations that can reach deep into the nucleoplasm and may even traverse the nucleus completely. Cancer cells are generally characterized by irregularities and invaginations of the NE that are of diagnostic and prognostic significance. In the current chapter, we describe the link between nuclear invaginations and irregularities with cancer and explore possible mechanistic roles they might have in tumorigenesis.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAbbreviations
- CCT-a:
-
CTP:phosphocholine-cytidylyltransferase-α
- HCC:
-
Hepatocellular carcinoma
- HGPS:
-
Hutchinson–Gilford Progeria Syndrome
- INM:
-
Inner nuclear membrane
- MARs:
-
Matrix attachment regions
- NE:
-
Nuclear envelope
- NR:
-
Nucleoplasmic reticulum
- PaCa:
-
Pancreatic carcinoma
References
Prunuske AJ, Ullman KS (2006) The nuclear envelope: form and reformation. Curr Opin Cell Biol 18(1):108–116. doi:10.1016/j.ceb.2005.12.004, S0955-0674(05)00185-7 [pii]
Dauer WT, Worman HJ (2009) The nuclear envelope as a signaling node in development and disease. Dev Cell 17(5):626–638. doi:10.1016/j.devcel.2009.10.016, S1534-5807(09)00438-9 [pii]
Mekhail K, Moazed D (2010) The nuclear envelope in genome organization, expression and stability. Nat Rev Mol Cell Biol 11(5):317–328. doi:10.1038/nrm2894, nrm2894 [pii]
Redwood AB, Perkins SM, Vanderwaal RP, Feng Z, Biehl KJ, Gonzalez-Suarez I, Morgado-Palacin L, Shi W, Sage J, Roti-Roti JL, Stewart CL, Zhang J, Gonzalo S (2011) A dual role for A-type lamins in DNA double-strand break repair. Cell Cycle 10(15):2549–2560. doi:16531 [pii]
Worman HJ (2012) Nuclear lamins and laminopathies. J Pathol 226(2):316–325. doi:10.1002/path.2999
Broers JL, Ramaekers FC, Bonne G, Yaou RB, Hutchison CJ (2006) Nuclear lamins: laminopathies and their role in premature ageing. Physiol Rev 86(3):967–1008. doi:10.1152/physrev. 00047.2005, 86/3/967 [pii]
Kamei H (1994) Relationship of nuclear invaginations to perinuclear rings composed of intermediate filaments in MIA PaCa-2 and some other cells. Cell Struct Funct 19(3):123–132
Fricker M, Hollinshead M, White N, Vaux D (1997) The convoluted nucleus. Trends Cell Biol 7(5):181. doi:S0962-8924(97)84084-6, [pii]10.1016/S0962-8924(97)84084-6
Fricker M, Hollinshead M, White N, Vaux D (1997) Interphase nuclei of many mammalian cell types contain deep, dynamic, tubular membrane-bound invaginations of the nuclear envelope. J Cell Biol 136(3):531–544
Schermelleh L, Carlton PM, Haase S, Shao L, Winoto L, Kner P, Burke B, Cardoso MC, Agard DA, Gustafsson MG, Leonhardt H, Sedat JW (2008) Subdiffraction multicolor imaging of the nuclear periphery with 3D structured illumination microscopy. Science 320(5881):1332–1336. doi:10.1126/science.1156947, 320/5881/1332 [pii]
Clubb BH, Locke M (1998) 3T3 cells have nuclear invaginations containing F-actin. Tissue Cell 30(6):684–691
Brandes D, Schofield BH, Anton E (1965) Nuclear mitochondria? Science 149(3690):1373–1374
Malhas A, Goulbourne C, Vaux DJ (2011) The nucleoplasmic reticulum: form and function. Trends Cell Biol 21(6):362–373. doi:10.1016/j.tcb.2011.03.008, S0962-8924(11)00050-X [pii]
True LD, Jordan CD (2008) The cancer nuclear microenvironment: interface between light microscopic cytology and molecular phenotype. J Cell Biochem 104(6):1994–2003. doi:10.1002/jcb.21478
Gupton SL, Collings DA, Allen NS (2006) Endoplasmic reticulum targeted GFP reveals ER organization in tobacco NT-1 cells during cell division. Plant Physiol Biochem 44(2–3):95–105. doi:10.1016/j.plaphy.2006.03.003, S0981-9428(06)00033-7 [pii]
Fischer AH, Taysavang P, Jhiang SM (2003) Nuclear envelope irregularity is induced by RET/PTC during interphase. Am J Pathol 163(3):1091–1100. doi:10.1016/S0002-9440(10)63468-2, S0002-9440(10)63468-2 [pii]
Bootman MD, Fearnley C, Smyrnias I, MacDonald F, Roderick HL (2009) An update on nuclear calcium signalling. J Cell Sci 122(Pt 14):2337–2350. doi:10.1242/jcs.028100, 122/14/2337 [pii]
Chow KH, Factor RE, Ullman KS (2012) The nuclear envelope environment and its cancer connections. Nat Rev Cancer 12(3):196–209. doi:10.1038/nrc3219, nrc3219 [pii]
Mounkes L, Kozlov S, Burke B, Stewart CL (2003) The laminopathies: nuclear structure meets disease. Curr Opin Genet Dev 13(3):223–230, S0959437X03000583 [pii]
McClintock D, Gordon LB, Djabali K (2006) Hutchinson-Gilford progeria mutant lamin A primarily targets human vascular cells as detected by an anti-Lamin A G608G antibody. Proc Natl Acad Sci U S A 103(7):2154–2159. doi:10.1073/pnas.0511133103, 0511133103 [pii]
De Sandre-Giovannoli A, Bernard R, Cau P, Navarro C, Amiel J, Boccaccio I, Lyonnet S, Stewart CL, Munnich A, Le Merrer M, Levy N (2003) Lamin a truncation in Hutchinson-Gilford progeria. Science 300(5628):2055. doi:10.1126/science.1084125, 1084125 [pii]
Scaffidi P, Misteli T (2006) Lamin A-dependent nuclear defects in human aging. Science 312(5776):1059–1063. doi:10.1126/science.1127168, 1127168 [pii]
Tang Y, Chen Y, Jiang H, Nie D (2010) Promotion of tumor development in prostate cancer by progerin. Cancer Cell Int 10:47. doi:10.1186/1475-2867-10-47, 1475-2867-10-47 [pii]
Zink D, Fischer AH, Nickerson JA (2004) Nuclear structure in cancer cells. Nat Rev Cancer 4(9):677–687. doi:10.1038/nrc1430, nrc1430 [pii]
Bussolati G, Marchio C, Gaetano L, Lupo R, Sapino A (2008) Pleomorphism of the nuclear envelope in breast cancer: a new approach to an old problem. J Cell Mol Med 12(1):209–218. doi:10.1111/j.1582-4934.2007.00176.x, JCMM176 [pii]
Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19(5):403–410
Boyd J, Pienta KJ, Getzenberg RH, Coffey DS, Barrett JC (1991) Preneoplastic alterations in nuclear morphology that accompany loss of tumor suppressor phenotype. J Natl Cancer Inst 83(12):862–866
Bloom HJ, Richardson WW (1957) Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 11(3): 359–377
Giardina C, Caniglia DM, D'Aprile M, Lettini T, Serio G, Cipriani T, Ricco R, Pesce Delfino V (1996) Nuclear morphometry in squamous cell carcinoma (SCC) of the tongue. Eur J Cancer B Oral Oncol 32B(2):91–96
Nativ O, Sabo E, Bejar J, Halachmi S, Moskovitz B, Miselevich I (1996) A comparison between histological grade and nuclear morphometry for predicting the clinical outcome of localized renal cell carcinoma. Br J Urol 78(1):33–38
Partin AW, Gearhart JP, Leonard MP, Leventhal BG, Yoo JK, Crooks D, Epstein JI, Beckwith JB (1993) The use of nuclear morphometry to predict prognosis in pediatric urologic malignancies: a review. Med Pediatr Oncol 21(3):222–229
Epstein JI, Berry SJ, Eggleston JC (1984) Nuclear roundness factor. A predictor of progression in untreated Stage A2 prostate cancer. Cancer 54(8):1666–1671
Mohler JL, Figlesthaler WM, Zhang XZ, Partin AW, Maygarden SJ (1994) Nuclear shape analysis for the assessment of local invasion and metastases in clinically localized prostate carcinoma. Cancer 74(11):2996–3001
Partin AW, Steinberg GD, Pitcock RV, Wu L, Piantadosi S, Coffey DS, Epstein JI (1992) Use of nuclear morphometry, gleason histologic scoring, clinical stage, and age to predict disease-free survival among patients with prostate cancer. Cancer 70(1):161–168
Liu CQ, Sasaki H, Fahey MT, Sakamoto A, Sato S, Tanaka T (1999) Prognostic value of nuclear morphometry in patients with TNM stage T1 ovarian clear cell adenocarcinoma. Br J Cancer 79(11–12):1736–1741. doi:10.1038/sj.bjc.6690276
Asioli S, Bussolati G (2009) Emerin immunohistochemistry reveals diagnostic features of nuclear membrane arrangement in thyroid lesions. Histopathology 54(5):571–579. doi:10.1111/j.1365-2559.2009.03259.x, HIS3259 [pii]
Asioli S, Maletta F, Pacchioni D, Lupo R, Bussolati G (2010) Cytological detection of papillary thyroid carcinomas by nuclear membrane decoration with emerin staining. Virchows Arch 457(1):43–51. doi:10.1007/s00428-010-0910-z
Batistatou A, Scopa CD (2009) Pathogenesis and diagnostic significance of nuclear grooves in thyroid and other sites. Int J Surg Pathol 17(2):107–110. doi:10.1177/1066896908316071, 1066896908316071 [pii]
Bussolati G (2008) Proper detection of the nuclear shape: ways and significance. Rom J Morphol Embryol 49(4):435–439, 490408435439 [pii]
Elisei R, Romei C, Vorontsova T, Cosci B, Veremeychik V, Kuchinskaya E, Basolo F, Demidchik EP, Miccoli P, Pinchera A, Pacini F (2001) RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults. J Clin Endocrinol Metab 86(7):3211–3216
Pisarchik AV, Ermak G, Fomicheva V, Kartel NA, Figge J (1998) The ret/PTC1 rearrangement is a common feature of Chernobyl-associated papillary thyroid carcinomas from Belarus. Thyroid 8(2):133–139
Santoro M, Sabino N, Ishizaka Y, Ushijima T, Carlomagno F, Cerrato A, Grieco M, Battaglia C, Martelli ML, Paulin C et al (1993) Involvement of RET oncogene in human tumours: specificity of RET activation to thyroid tumours. Br J Cancer 68(3):460–464
Fischer AH, Bond JA, Taysavang P, Battles OE, Wynford-Thomas D (1998) Papillary thyroid carcinoma oncogene (RET/PTC) alters the nuclear envelope and chromatin structure. Am J Pathol 153(5):1443–1450. doi:10.1016/S0002-9440(10)65731-8, S0002-9440(10)65731-8 [pii]
Wynford-Thomas D (1997) Origin and progression of thyroid epithelial tumours: cellular and molecular mechanisms. Horm Res 47(4–6):145–157
Fischer AH, Taysavang P, Weber CJ, Wilson KL (2001) Nuclear envelope organization in papillary thyroid carcinoma. Histol Histopathol 16(1):1–14
Franke WW, Schinko W (1969) Nuclear shape in muscle cells. J Cell Biol 42(1):326–331
Lane BP (1965) Alterations in the cytologic detail of intestinal smooth muscle cells in various stages of contraction. J Cell Biol 27(1):199–213
Dey P (2010) Cancer nucleus: morphology and beyond. Diagn Cytopathol 38(5):382–390. doi:10.1002/dc.21234
Luo RX, Postigo AA, Dean DC (1998) Rb interacts with histone deacetylase to repress transcription. Cell 92(4):463–473, S0092-8674(00)80940-X [pii]
Robertson KD, Ait-Si-Ali S, Yokochi T, Wade PA, Jones PL, Wolffe AP (2000) DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters. Nat Genet 25(3):338–342. doi:10.1038/77124
Nielsen SJ, Schneider R, Bauer UM, Bannister AJ, Morrison A, O'Carroll D, Firestein R, Cleary M, Jenuwein T, Herrera RE, Kouzarides T (2001) Rb targets histone H3 methylation and HP1 to promoters. Nature 412(6846):561–565. doi:10.1038/35087620, 35087620 [pii]
Vandel L, Nicolas E, Vaute O, Ferreira R, Ait-Si-Ali S, Trouche D (2001) Transcriptional repression by the retinoblastoma protein through the recruitment of a histone methyltransferase. Mol Cell Biol 21(19):6484–6494
Marshall WF (2002) Order and disorder in the nucleus. Curr Biol 12(5):R185–R192, S0960982202007248 [pii]
Pickersgill H, Kalverda B, de Wit E, Talhout W, Fornerod M, van Steensel B (2006) Characterization of the Drosophila melanogaster genome at the nuclear lamina. Nat Genet 38(9):1005–1014. doi:10.1038/ng1852, ng1852 [pii]
Guelen L, Pagie L, Brasset E, Meuleman W, Faza MB, Talhout W, Eussen BH, de Klein A, Wessels L, de Laat W, van Steensel B (2008) Domain organization of human chromosomes revealed by mapping of nuclear lamina interactions. Nature 453(7197):948–951. doi:10.1038/nature06947, nature06947 [pii]
Parada L, Misteli T (2002) Chromosome positioning in the interphase nucleus. Trends Cell Biol 12(9):425–432, S0962892402023516 [pii]
Cremer T, Cremer M, Dietzel S, Muller S, Solovei I, Fakan S (2006) Chromosome territories–a functional nuclear landscape. Curr Opin Cell Biol 18(3):307–316. doi:10.1016/j.ceb.2006.04.007, S0955-0674(06)00056-1 [pii]
Gandhi MS, Stringer JR, Nikiforova MN, Medvedovic M, Nikiforov YE (2009) Gene position within chromosome territories correlates with their involvement in distinct rearrangement types in thyroid cancer cells. Genes Chromosomes Cancer 48(3):222–228. doi:10.1002/gcc.20639
Heng HH, Goetze S, Ye CJ, Liu G, Stevens JB, Bremer SW, Wykes SM, Bode J, Krawetz SA (2004) Chromatin loops are selectively anchored using scaffold/matrix-attachment regions. J Cell Sci 117(Pt 7):999–1008. doi:10.1242/jcs.00976, 117/7/999 [pii]
Cai S, Han HJ, Kohwi-Shigematsu T (2003) Tissue-specific nuclear architecture and gene expression regulated by SATB1. Nat Genet 34(1):42–51. doi:10.1038/ng1146 ng1146 [pii]
Schwartz GH, Patnaik A, Hammond LA, Rizzo J, Berg K, Von Hoff DD, Rowinsky EK (2003) A phase I study of bizelesin, a highly potent and selective DNA-interactive agent, in patients with advanced solid malignancies. Ann Oncol 14(5):775–782
Goulbourne CN, Malhas AN, Vaux DJ (2011). The induction of a nucleoplasmic reticulum by prelamin A accumulation requires CTP:phosphocholine cytidylyltransferase-alpha. J Cell Sci 124 (Pt 24):4253–4266. doi:jcs.091009 [pii]10.1242/jcs.091009
Leighl NB, Dent S, Clemons M, Vandenberg TA, Tozer R, Warr DG, Crump RM, Hedley D, Pond GR, Dancey JE, Moore MJ (2008) A Phase 2 study of perifosine in advanced or metastatic breast cancer. Breast Cancer Res Treat 108(1):87–92. doi:10.1007/s10549-007-9584-x
Su JS, Woods SM, Ronen SM (2012) Metabolic consequences of treatment with AKT inhibitor perifosine in breast cancer cells. NMR Biomed 25(2):379–388. doi:10.1002/nbm.1764
Helfand BT, Wang Y, Pfleghaar K, Shimi T, Taimen P, Shumaker DK (2012) Chromosomal regions associated with prostate cancer risk localize to lamin B-deficient microdomains and exhibit reduced gene transcription. J Pathol 226(5):735–745. doi:10.1002/path.3033
Helfand BT, Loeb S, Cashy J, Meeks JJ, Thaxton CS, Han M, Catalona WJ (2008) Tumor characteristics of carriers and noncarriers of the deCODE 8q24 prostate cancer susceptibility alleles. J Urol 179(6):2197–2201. doi:10.1016/j.juro.2008.01.110, discussion 2202. S0022-5347(08)00257-7 [pii]
Staebler A, Karberg B, Behm J, Kuhlmann P, Neubert U, Schmidt H, Korsching E, Burger H, Lelle R, Kiesel L, Bocker W, Shih Ie M, Buchweitz O (2006) Chromosomal losses of regions on 5q and lack of high-level amplifications at 8q24 are associated with favorable prognosis for ovarian serous carcinoma. Genes Chromosomes Cancer 45(10):905–917. doi:10.1002/gcc.20356
Hewitt SL, High FA, Reiner SL, Fisher AG, Merkenschlager M (2004) Nuclear repositioning marks the selective exclusion of lineage-inappropriate transcription factor loci during T helper cell differentiation. Eur J Immunol 34(12):3604–3613. doi:10.1002/eji.200425469
Chuang CH, Carpenter AE, Fuchsova B, Johnson T, de Lanerolle P, Belmont AS (2006) Long-range directional movement of an interphase chromosome site. Curr Biol 16(8):825–831. doi:10.1016/j.cub.2006.03.059, S0960-9822(06)01356-X [pii]
Malhas A, Lee CF, Sanders R, Saunders NJ, Vaux DJ (2007) Defects in lamin B1 expression or processing affect interphase chromosome position and gene expression. J Cell Biol 176(5):593–603. doi:10.1083/jcb.200607054, jcb.200607054 [pii]
Ruault M, Dubarry M, Taddei A (2008) Re-positioning genes to the nuclear envelope in mammalian cells: impact on transcription. Trends Genet 24(11):574–581. doi:10.1016/j.tig.2008.08.008, S0168-9525(08)00228-X [pii]
Heessen S, Fornerod M (2007) The inner nuclear envelope as a transcription factor resting place. EMBO Rep 8(10):914–919. doi:10.1038/sj.embor.7401075, 7401075 [pii]
Gonzalez JM, Navarro-Puche A, Casar B, Crespo P, Andres V (2008) Fast regulation of AP-1 activity through interaction of lamin A/C, ERK1/2, and c-Fos at the nuclear envelope. J Cell Biol 183(4):653–666. doi:10.1083/jcb.200805049, jcb.200805049 [pii]
Malhas AN, Lee CF, Vaux DJ (2009) Lamin B1 controls oxidative stress responses via Oct-1. J Cell Biol 184(1):45–55. doi:10.1083/jcb.200804155, jcb.200804155 [pii]
Malhas A, Saunders NJ, Vaux DJ (2010) The nuclear envelope can control gene expression and cell cycle progression via miRNA regulation. Cell Cycle 9(3):531–539, 10511 [pii]
Bandres E, Cubedo E, Agirre X, Malumbres R, Zarate R, Ramirez N, Abajo A, Navarro A, Moreno I, Monzo M, Garcia-Foncillas J (2006) Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer 5:29. doi:10.1186/1476-4598-5-29, 1476-4598-5-29 [pii]
Slaby O, Svoboda M, Fabian P, Smerdova T, Knoflickova D, Bednarikova M, Nenutil R, Vyzula R (2007) Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology 72(5–6):397–402. doi:10.1159/000113489, 000113489 [pii]
Valastyan S, Reinhardt F, Benaich N, Calogrias D, Szasz AM, Wang ZC, Brock JE, Richardson AL, Weinberg RA (2009) A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 137(6):1032–1046. doi:10.1016/j.cell.2009.03.047, S0092-8674(09)00390-0 [pii]
Valastyan S, Chang A, Benaich N, Reinhardt F, Weinberg RA (2011) Activation of miR-31 function in already-established metastases elicits metastatic regression. Genes Dev 25(6):646–659. doi:10.1101/gad.2004211, 25/6/646 [pii]
Szafranska AE, Davison TS, John J, Cannon T, Sipos B, Maghnouj A, Labourier E, Hahn SA (2007) MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene 26(30):4442–4452. doi:10.1038/sj.onc.1210228, 1210228 [pii]
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Malhas, A.N., Vaux, D.J. (2014). Nuclear Envelope Invaginations and Cancer. In: Schirmer, E., de las Heras, J. (eds) Cancer Biology and the Nuclear Envelope. Advances in Experimental Medicine and Biology, vol 773. Springer, New York, NY. https://doi.org/10.1007/978-1-4899-8032-8_24
Download citation
DOI: https://doi.org/10.1007/978-1-4899-8032-8_24
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4899-8031-1
Online ISBN: 978-1-4899-8032-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)